Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis

NCT00086164 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Hyperplasia
Chronic Renal Failure

Interventions

DRUG: edifoligide (E2F Decoy)

Sponsor

Anesiva, Inc.